AC-03. Clinical Pharmacodynamics and Activity of Antibacterials
Originally Presented: March 19, 2008
Speaker: Scott Bergman
Summary of Session: Pharmacodynamics is the study of how drugs affect the body and therefore microorganisms within it. When antibacterials are first studied, little is known about the pharmacodynamic effect they will have against microorganisms in patients. This science becomes especially important when treating infectious diseases because of the relationship between antimicrobial concentrations, microorganism eradication, and the development of resistance. This session will explore the clinical usefulness of antibiotics against common pathogens in the era of antibacterial resistance and the role of pharmacodynamics in preventing or overcoming resistance.
Objectives: Upon completion of this Teleconference, participants should be able to:
- Review the spectrums of activity for clinically important antibacterial agents
- Compare the mechanisms of action for commonly used antibacterials
- Differentiate between agents with concentration-dependent and time-dependent activity
- Classify the activity of certain antibacterials as being primarily bactericidal or bacteriostatic
Intended Audience: Those working in clinical microbiology, infection control, and infectious diseases
CME Disclosures: Scott Berman, PharmD has disclosed the following commerical relationship relevant to his presentation:
Pfizer - Speaker's Bureau
Ortho-McNeil - Speaker's Bureau
ASM Policy on Faculty Discussion of Unapproved or Unlabeled Uses of Drugs of Devices
In accordance with the ACCME Essential Areas and Policies relating to commercial support, the audience is advised that Dr. Scott Bergman will not be discussing any off-label usage of products.
Termination of CME Credit: This program will not be eligible for CME/CE credit after March 19, 2009
|